Categories: Machinery/ Equipments

Views on 100% FDI in Medical devices by Dr. GSK Velu, Trivitron


BY DR. GSK VELU, FOUNDER AND MANAGING DIRECTOR, TRIVITRON GROUP OF COMPANIES:
New Delhi, Jan 03, 2015: 
“While 100‎% FDI in Medical Devices sector is a welcome in our opinion this was already in existence and many MNCs have 100% subsidiaries in India though predominantly with trading and distribution focus. As a part of this new initiative actions should be taken to control and restrict 100% trading subsidiary operations in India. These trading subsidiaries does not have any manufacturing intent and in fact even distribution margins are being expatriated back to their parent countries by adopting several means. Hence apart from 100% FDI in Medical Devices sector government should create right eco system for manufacturing in the country which presently has ” Pro Imports” policies with Inverse Duty structure, lack of control on imports using High Sea Sales route and no coordinated efforts between Academia/ Indian Industry in the R&D initiatives. While MNC s should be encouraged to come and manufacture in India, Indian Domestic companies with majority Indian Ownership should be given special preference in Govt Procurement etc as it is happening in other countries like China, Turkey, Brazil, Russia and many other countries. We sincerely hope a New Medical Devices wing will be created under Department of Pharmaceuticals to promote Indigenous Medical Devices companies by understanding and attending to their needs in this budget.

But overall it is a good news Government is willing to listen to the views of over 750 Indian Manufacturers in this segment and implement changes to the tariff structure and regulatory structure in the upcoming budget. Indian Manufacturers are of the view Government should do away with 100% Customs duty exemption for all product categories as this has not benefited the end patients over the past two decades. As per the recent reports in the media, a Drug Eluting Stent which is being manufactured for Rs 5000 is being imported to India with around Rs 40,000 with nil Customs Duty and the end patient pays around Rs 1.5 lakhs for the same. Hence there is no rationale for Zero Customs duty for any Finished Goods imports and there should be atleast 20% customs duty exemption between Finished Goods imports and Raw Materials/ Components import for ultimate manufacturing in the country. Hence there is an urgent need to boost innovation and manufacturing in this Industry of 35,000 crs with over 80% imports and as a largest Medical Technology company of Indian Origin with 8 Functional US FDA and/or CE certified facilities and 4 R&D facilities, Trivitron is in the forefront of interacting with government through various industry associations like FICCI, AIMED and Assocham to create the right eco system for the Medical Devices Industry to remove import dependency and make India Outward looking with substantial exports in around 5 to 10 years from now.”CCI Newswire
The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

12 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

12 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

1 day ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

2 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago